MaxCyte, Inc. (MXCT.L)

GBp 346.0

(0.87%)

Operating Expenses Summary of MaxCyte, Inc.

  • MaxCyte, Inc.'s latest annual operating expenses in 2023 was 84.84 Million USD , up 27.54% from previous year.
  • MaxCyte, Inc.'s latest quarterly operating expenses in 2024 Q2 was 20.9 Million USD , down -5.87% from previous quarter.
  • MaxCyte, Inc. reported a annual operating expenses of 66.52 Million USD in annual operating expenses 2022, up 37.35% from previous year.
  • MaxCyte, Inc. reported a annual operating expenses of 48.43 Million USD in annual operating expenses 2021, up 40.56% from previous year.
  • MaxCyte, Inc. reported a quarterly operating expenses of 20.9 Million USD for 2024 Q2, down -5.87% from previous quarter.
  • MaxCyte, Inc. reported a quarterly operating expenses of 20.75 Million USD for 2023 Q1, up 17.74% from previous quarter.

Annual Operating Expenses Chart of MaxCyte, Inc. (2023 - 2012)

Historical Annual Operating Expenses of MaxCyte, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 84.84 Million USD 27.54%
2022 66.52 Million USD 37.35%
2021 48.43 Million USD 40.56%
2020 34.45 Million USD 9.25%
2019 31.54 Million USD 35.65%
2018 23.25 Million USD 6.54%
2017 21.82 Million USD 59.47%
2016 13.68 Million USD 51.73%
2015 9.01 Million USD 20.54%
2014 7.48 Million USD 10.02%
2013 6.8 Million USD 9.84%
2012 6.19 Million USD 0.0%

Peer Operating Expenses Comparison of MaxCyte, Inc.

Name Operating Expenses Operating Expenses Difference